How France became the new Eldorado for digital health reimbursement? Har passerat
Onsdag 24 maj 2023 15:30 - 15:55 F5
Föreläsare: Ouassim NAIET EL GAIED
France has been a pioneer in the evaluation of how to find a way to utilize remote monitoring / telemedicine, including several pilot programs. Based on this experience a permanent pathway (LATM) for remote monitoring is in final stages to be implemented.
With the creation of this permanent pathway for remote monitoring and the clarification of the reimbursement scope of digital therapeutics (DTx), France has now a very broad scope of digital health reimbursement schemes.
Different pathways and tariffication possibilities are now possible depending on the digital health solution’s features and generated evidence (organizational, clinical, economic benefits).
During this presentation we will talk about the French experience with digital health reimbursement with some key takeaways on the processes and requirements. We will also share with you our experience on the pitfalls to avoid when accessing French digital health market.
Språk
English
Seminarietyp
Livesänd
Föreläsningssyfte
Orientering
Kunskapsnivå
Fördjupning
Målgrupp
Chef/Beslutsfattare
Politiker
Upphandlare/inköp/ekonomi/HR
Tekniker/IT/Utvecklare
Forskare (även studerande)
Studerande
Omsorgspersonal
Vårdpersonal
Nyckelord
Exempel från verkligheten (goda/dåliga)
Välfärdsutveckling
Innovativ/forskning
Uppföljning/Nulägesbeskrivning
Appar
Juridik
Konferens
Vitalis
Föreläsare
Ouassim NAIET EL GAIED Föreläsare
Market Access consultant
MediTech Access
Highly qualified pharmacist with a Master's degree in international regulatory affairs and a university diploma in Market Access & Health Economics.
Ouassim is a Market Access expert specialized in digital health at MediTech Access, a French consulting firm at the forefront of the most important milestones for digital health reimbursement in France, including the remote patient monitoring experiment (ETAPES), the first HTA assessment dossiers for digital health solutions, and the new remote monitoring reimbursement and PECAN frameworks.
He is actually responsible for managing digital health projects at MediTech Access where he is dedicated to supporting startups and MedTech companies in gaining early access and/or reimbursement for their medical devices. Prior to joining MediTech Access, Ouassim managed early market access phases for connected medical devices at BioSerenity, a start-up specializing in cardiology, neurology, and sleep medicine. He was also a Market Access intern at Air Liquide Healthcare, where he was involved in the development of a digital solution in oncology.